Rituximab or cyclophosphamide in ANCA-associated renal vasculitis
- PMID: 21083401
- DOI: 10.1056/NEJMc1009101
Rituximab or cyclophosphamide in ANCA-associated renal vasculitis
Comment on
-
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.N Engl J Med. 2010 Jul 15;363(3):211-20. doi: 10.1056/NEJMoa0909169. N Engl J Med. 2010. PMID: 20647198 Clinical Trial.
-
Rituximab versus cyclophosphamide for ANCA-associated vasculitis.N Engl J Med. 2010 Jul 15;363(3):221-32. doi: 10.1056/NEJMoa0909905. N Engl J Med. 2010. PMID: 20647199 Free PMC article. Clinical Trial.
Similar articles
-
Rituximab or cyclophosphamide in ANCA-associated renal vasculitis.N Engl J Med. 2010 Nov 18;363(21):2072-3; author reply 2073-4. doi: 10.1056/NEJMc1009101. N Engl J Med. 2010. PMID: 21083399 No abstract available.
-
Rituximab or cyclophosphamide in ANCA-associated renal vasculitis.N Engl J Med. 2010 Nov 18;363(21):2072; author reply 2073-4. doi: 10.1056/NEJMc1009101. N Engl J Med. 2010. PMID: 21083400 No abstract available.
-
Rituximab or cyclophosphamide in ANCA-associated renal vasculitis.N Engl J Med. 2010 Nov 18;363(21):2073; author reply 2073-4. doi: 10.1056/NEJMc1009101. N Engl J Med. 2010. PMID: 21083398 No abstract available.
-
Rituximab for ANCA-associated vasculitides.Clin Exp Rheumatol. 2014 May-Jun;32(3 Suppl 82):S118-21. Epub 2014 May 16. Clin Exp Rheumatol. 2014. PMID: 24854382 Review.
-
L52. Vasculitis treatment: is it time to change the standard of care for ANCA-associated vasculitis?Presse Med. 2013 Apr;42(4 Pt 2):643-50. doi: 10.1016/j.lpm.2013.01.047. Epub 2013 Mar 6. Presse Med. 2013. PMID: 23474045 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical